Cyril Gay | Senior National Program Leader
A.R.S. National Programs

Cyril Gay, Senior National Program Leader, A.R.S. National Programs

Dr. Gay obtained a B.Sc. in Chemistry and a Doctor of Veterinary Medicine from Auburn University, and a Ph.D. in Microbiology from The George Washington University.  Dr. Gay has worked in the animal health research field for the last 25 years holding several positions of increasing responsibility in the federal government and the pharmaceutical industry.  As Chief, Biotechnology Section, Center for Veterinary Biologics (CVB), United States Department of Agriculture (USDA), Dr. Gay developed the procedures for licensing molecular vaccines that led to the first license for a live recombinant vectored vaccine.  In the pharmaceutical industry (SmithKline Beecham Animal Health and Pfizer Animal Health) Dr. Gay led several cross-functional teams that successfully developed and licensed veterinary vaccines for companion animals and livestock.  As Director, Global Product Development, Pfizer Inc., Dr. Gay developed strategic and tactical plans that interfaced R&D, clinical development, manufacturing, marketing, and product life-cycle management.  Dr. Gay joined Agricultural Research Service (ARS), USDA, in 2002.  Dr. Gay currently holds the position of Senior National Program Leader and provides program direction and national coordination for the Department’s intramural animal health research program, with focus on eight research laboratories located in Ames, Iowa, East Lansing, Michigan, Clay Center, Nebraska, Athens, Georgia, Orient Point, New York, Beltsville, Maryland, Pullman, Washington, and Manhattan, Kansas.  Dr. Gay was the 2010 recipient of the USDA Secretary’s Honors Award for interagency response to the pandemic H1N1 influenza outbreak; the ARS Special Administrator’s Award for outstanding and rapid research support for pandemic H1N1; and the USDA Secretary’s Honor Award for Heroism and Emergency Response for contributions as a team member to the ARS/APHIS response to the 2013 Chinese H7N9 avian influenza outbreak.


April 15 Plenary Congress Day 1 @ 14:40

The role of vaccines to combat antibiotic-microbial resistance

  • What can we do to manage AMR? The mis-use of Abx in bacterial and viral infections
  • How vaccine regulatory and access policies can be used to strengthen utilization of vaccines as a component of multi-pronged strategies that governments should take in their national action plans to address AMR
  • The need for a holistic and collaborative strategy including cross species considerations

April 16 Day 2 - 10 Co-conferences @ 09:00

Chair’s opening remarks

April 17 Day 3 - 10 Co-conferences & Plenary @ 09:00

Chair’s opening remarks

last published: 11/Apr/19 16:05 GMT

back to speakers

Sign Up for Event Updates

Get Involved At World Vaccine Congress Washington


To Sponsor Or Exhibit

Marc Rhys-Evans
+44 20 7827 5945




To Register

Tayyab Abbasi
+44 20 7092 1210




Press Relations

Karina Kusova
+44 20 7092 1071